Incidence and risk factors for glaucoma development and progression after corneal transplantation

[1]  M. Harissi-Dagher,et al.  Glaucoma Risk Factors and Outcomes Following Boston Keratoprosthesis Type 1 Surgery. , 2021, American journal of ophthalmology.

[2]  M. Makary,et al.  Postoperative complications in Medicare beneficiaries following endothelial keratoplasty (EK) surgery. , 2020, American journal of ophthalmology.

[3]  Lucy Q. Shen,et al.  Glaucoma Management in Patients with Aniridia and Boston Type 1 Keratoprosthesis. , 2019, American journal of ophthalmology.

[4]  D. Musch,et al.  Corneal Edema and Opacification Preferred Practice Pattern®. , 2024, Ophthalmology.

[5]  A. Coleman,et al.  Risk of Glaucoma Surgery After Corneal Transplant Surgery in Medicare Patients. , 2018, American journal of ophthalmology.

[6]  J. Mehta,et al.  Incidence and Risk Factors of Elevated Intraocular Pressure Following Deep Anterior Lamellar Keratoplasty. , 2016, American journal of ophthalmology.

[7]  J. Nordmann,et al.  Incidence of Intraocular Pressure Elevation and Glaucoma after Lamellar versus Full-Thickness Penetrating Keratoplasty. , 2016, Ophthalmology.

[8]  Sheng Zhou,et al.  Boston Keratoprosthesis Outcomes in Severe Ocular Chemical Burns in Southern China: A Retrospective Study , 2016, Advances in Therapy.

[9]  L. Bursztyn,et al.  Comparison of intraocular pressure post penetrating keratoplasty vs Descemet's stripping endothelial keratoplasty. , 2016, Canadian journal of ophthalmology. Journal canadien d'ophtalmologie.

[10]  A. Coleman,et al.  Burden of undetected and untreated glaucoma in the United States. , 2014, American journal of ophthalmology.

[11]  A. Joussen,et al.  Intraocular pressure elevation and post-DMEK glaucoma following Descemet membrane endothelial keratoplasty , 2014, Graefe's Archive for Clinical and Experimental Ophthalmology.

[12]  F. Hirai,et al.  Experience with Boston keratoprosthesis type 1 in the developing world. , 2014, Canadian journal of ophthalmology. Journal canadien d'ophtalmologie.

[13]  A. Sharma,et al.  Post penetrating keratoplasty glaucoma: Cumulative effect of quantifiable risk factors , 2014, Indian journal of ophthalmology.

[14]  A. Joussen,et al.  Intraocular pressure elevation and post-DSEK glaucoma after Descemet`s stripping endothelial keratoplasty , 2013, Graefe's Archive for Clinical and Experimental Ophthalmology.

[15]  P. Galloway,et al.  Long‐term risk of intraocular pressure elevation and glaucoma escalation after deep anterior lamellar keratoplasty , 2012, Clinical & experimental ophthalmology.

[16]  K. Tsubota,et al.  Intraocular pressure elevation after Descemet’s stripping endothelial keratoplasty , 2012, Japanese Journal of Ophthalmology.

[17]  I. Dapena,et al.  Causes of glaucoma after descemet membrane endothelial keratoplasty. , 2012, American journal of ophthalmology.

[18]  M. Harissi-Dagher,et al.  Prevalence, progression, and impact of glaucoma on vision after Boston type 1 keratoprosthesis surgery. , 2012, American journal of ophthalmology.

[19]  A. Joussen,et al.  Glaucoma in penetrating keratoplasty: risk factors, management and outcome , 2012, Graefe's Archive for Clinical and Experimental Ophthalmology.

[20]  A. Şahin,et al.  Glaucoma after Penetrating Keratoplasty: Incidence, Risk Factors, and Management , 2011, Journal of ophthalmology.

[21]  A. Hofman,et al.  Defining Glaucomatous Optic Neuropathy from a Continuous Measure of Optic Nerve Damage – The Optimal Cut-off Point for Risk-factor Analysis in Population-based Epidemiology , 2011, Ophthalmic epidemiology.

[22]  L. Lim,et al.  Postoperative risk factors influencing corneal graft survival in the Singapore Corneal Transplant Study. , 2011, American journal of ophthalmology.

[23]  C. Foster,et al.  Durezol (Difluprednate Ophthalmic Emulsion 0.05%) compared with Pred Forte 1% ophthalmic suspension in the treatment of endogenous anterior uveitis. , 2010, Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics.

[24]  J. Wilensky,et al.  Visual acuity and intraocular pressure after Descemet's stripping endothelial keratoplasty in eyes with and without preexisting glaucoma. , 2009, Ophthalmology.

[25]  P. Harris,et al.  Research electronic data capture (REDCap) - A metadata-driven methodology and workflow process for providing translational research informatics support , 2009, J. Biomed. Informatics.

[26]  M. Wagoner,et al.  Escalation of glaucoma therapy after penetrating keratoplasty. , 2007, Ophthalmology.

[27]  M. C. Leske,et al.  Predictors of long-term progression in the early manifest glaucoma trial. , 2007, Ophthalmology.

[28]  Yong Yeon Kim,et al.  Distribution and Characteristics of Peripheral Anterior Synechiae in Primary Angle-Closure Glaucoma , 2006, Korean journal of ophthalmology : KJO.

[29]  A. Viswanathan,et al.  Risk factors for elevated intraocular pressure in uveitis. , 2004 .

[30]  R. Klein,et al.  Causes and prevalence of visual impairment among adults in the United States. , 2004, Archives of ophthalmology.

[31]  Anders Heijl,et al.  Factors for glaucoma progression and the effect of treatment: the early manifest glaucoma trial. , 2003, A M A Archives of Ophthalmology.

[32]  N. Bodor.  Designing safer ophthalmic drugs by soft drug approaches. , 1994, Journal of ocular pharmacology.

[33]  W. Ryan,et al.  Comparative anti-inflammatory efficacy of topical corticosteroids with low glaucoma-inducing potential. , 1992, Archives of ophthalmology.

[34]  S. I. Brown,et al.  Incidence of increased intraocular pressure after keratoplasty. , 1981, American journal of ophthalmology.